Gyre Therapeutics, Inc. (GYRE) Operating income 2016–2025
Gyre Therapeutics, Inc. (GYRE) annual operating income history from SEC filings — each fiscal year as reported.
$11.5MFY2025 · since FY2016: -$20.4M → $11.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.5M | -28.9% |
| FY2024 | $16.2M | +124.0% |
| FY2023 | -$67.2M | -830.5% |
| FY2022 | $9.2M | +110.5% |
| FY2021 | -$87.9M | -53.2% |
| FY2020 | -$57.4M | -0.2% |
| FY2019 | -$57.3M | -69.3% |
| FY2018 | -$33.8M | -55.0% |
| FY2017 | -$21.8M | -6.9% |
| FY2016 | -$20.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice